Iridium-Catalyzed C-H Activation and Deuteration of Primary Sulfonamides: An Experimental and Computational Study

ACS Catalysis

Volumn 5, Issue 1, 2015, Pages 402-410

  Kerr, William J ^a   Reid, Marc ^a   Tuttle, Tell ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

C H activation; hydrogen isotope exchange; iridium; ortho deuteration; sulfonamide

Indexed keywords

ACTIVATION ANALYSIS; AMIDES; CATALYSIS; CATALYSTS; CHEMICAL ACTIVATION; CHLORINE COMPOUNDS; DEUTERIUM; HYDROGEN; ISOTOPES; ORGANIC COMPOUNDS; SUBSTRATES; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

AMBIENT CONDITIONS; C-H ACTIVATION; CHEMO-SELECTIVITY; COMPUTATIONAL STUDIES; DEUTERATIONS; HYDROGEN ISOTOPE EXCHANGE; N-HETEROCYCLIC CARBENES; SULFONAMIDE;

IRIDIUM;

EID: 84923910059     PISSN: 21555435     EISSN: None     Source Type: Journal    
DOI: 10.1021/cs5015755     Document Type: Article

References (63)

1. Murai, S.; Kakiuchi, F.; Sekine, S.; Tanaka, Y.; Kamatani, A.; Sonoda, M.; Chatani, N. Nature 1993, 366, 529 - 531 10.1038/366529a0
2. Lewis, L. N.; Smith, J. F. J. Am. Chem. Soc. 1986, 108, 2728 - 2730 10.1021/ja00270a036
3. Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010, 110, 1147 - 1169 10.1021/cr900184e
4. Chiusoli, G. P.; Catellani, M.; Costa, M.; Motti, E.; Ca', N. D.; Maestra, G. Coord. Chem. Rev. 2010, 254, 456 - 469 10.1016/j.ccr.2009.07.023
5. Balcells, D.; Clot, E.; Eisenstein, O. Chem. Rev. 2010, 110, 749 - 823 10.1021/cr900315k
6. Colby, D. A.; Bergman, R. G.; Ellman, J. A. Chem. Rev. 2010, 110, 624 - 655 10.1021/cr900005n
7. Giri, R.; Shi, B.-F.; Engle, K. M.; Maugel, N.; Yu, J.-Q. Chem. Soc. Rev. 2009, 38, 3242 - 3272 10.1039/b816707a
8. McGlacken, G. P.; Bateman, L. M. Chem. Soc. Rev. 2009, 38, 2447 - 2464 10.1039/b805701j
9. Thansandote, P.; Lautens, M. Chem.-Eur. J. 2009, 15, 5874 - 5883 10.1002/chem.200900281
10. For selected reviews, see: Lockley, W. J. S.; McEwen, A.; Cooke, R. J. Label. Compd. Radiopharm. 2012, 55, 235 - 257 10.1002/jlcr.2928
11. Allen, P. H.; Hickey, M. J.; Kingston, L. P.; Wilkinson, D. J. J. Label. Compd. Radiopharm. 2010, 53, 731 - 738 10.1002/jlcr.1825
12. Nilsson, G. N.; Kerr, W. J. J. Label. Compd. Radiopharm. 2010, 53, 662 - 667 10.1002/jlcr.1817
13. Salter, R. J. Label. Compd. Radiopharm. 2010, 53, 645 - 657 10.1002/jlcr.1814
14. Heys, J. R. J. Label. Compd. Radiopharm. 2007, 50, 770 - 778 10.1002/jlcr.1428
15. Atzrodt, J.; Derdau, V.; Fey, T.; Zimmermann, J. Angew. Chem., Int. Ed. 2007, 46, 7744 - 7765 10.1002/anie.200700039
16. Parmentier, M.; Hartung, T.; Pfaltz, A.; Muri, D. Chem.-Eur. J. 2014, 20, 11496 - 11504 10.1002/chem.201402078
17. Isin, E. M.; Elmore, C. S.; Nilsson, G. N.; Thompson, R. A.; Weidolf, L. Chem. Res. Toxicol. 2012, 25, 532 - 542 10.1021/tx2005212
18. Heys, J. R. J. Chem. Soc., Chem. Commun. 1992, 680 - 681 10.1039/c39920000680
19. Lehamn, M. C.; Gary, J. B.; Boyle, B. D.; Sanford, M. S.; Ison, E. A. ACS Catal. 2013, 3, 2304 - 2310 10.1021/cs400420n
20. Rhinehart, J. L.; Manbeck, K. A.; Buzak, S. K.; Lippa, G. M.; Brennessel, W. W.; Goldberg, K. I.; Jones, W. D. Organometallics 2012, 31, 1943 - 1952 10.1021/om2012419
21. Feng, Y.; Jiang, B.; Boyle, P. A.; Ison, E. A. Organometallics 2010, 29, 2857 - 2867 10.1021/om100018x
22. Brown, J. A.; Irvine, S.; Kennedy, A. R.; Kerr, W. J.; Andersson, S.; Nilsson, G. N. Chem. Commun. 2008, 1115 - 1117 10.1039/b715938b
23. Cochrane, A. R.; Idziak, C.; Kerr, W. J.; Mondal, B.; Paterson, L. C.; Tuttle, T.; Andersson, S.; Nilsson, G. N. Org. Biomol. Chem. 2014, 12, 3598 - 3603 10.1039/c4ob00465e
24. Brown, J. A.; Cochrane, A. R.; Irvine, S.; Kerr, W. J.; Mondal, B.; Parkinson, J. A.; Paterson, L. C.; Reid, M.; Tuttle, T.; Andersson, S.; Nilsson, G. N. Adv. Synth. Catal. 2014, 356, 3551 - 3562 10.1002/adsc.201400730
25. Kennedy, A. R.; Kerr, W. J.; Moir, R.; Reid, M. Org. Biomol. Chem. 2014, 12, 7927 - 7931 10.1039/C4OB01570C
26. Kerr, W. J.; Mudd, R. J.; Paterson, L. C.; Brown, J. A. Chem.-Eur. J. 2014, 20, 14604 - 14607 10.1002/chem.201405114
27. Walsh, C. Nat. Rev. Microbiol. 2003, 1, 65 - 70 10.1038/nrmicro727
28. Drews, J. Science 2000, 287, 1960 - 1964 10.1126/science.287.5460.1960
29. Kalgutkar, A. S.; Jones, R.; Sawant, A. In Metabolism, Pharmacokinetics and Toxicology of Functional Groups; Smith, D. A., Ed.; RSC: Cambridge, U.K., 2010; RSC Drug Discovery Series No. 1, Chapter 5.
30. Dai, H.-X.; Stepan, A. F.; Plummer, M. S.; Zhang, Y.-H.; Yu, J.-Q. J. Am. Chem. Soc. 2011, 133, 7222 - 7228 10.1021/ja201708f
31. Miura, M.; Tsuda, T.; Satoh, T.; Pivsa-Art, S.; Nomura, M. J. Org. Chem. 1998, 63, 5211 - 5215 10.1021/jo980584b
32. Pham, M. V.; Ye, B.; Cramer, N. Angew. Chem., Int. Ed. 2012, 51, 10610 - 10614 10.1002/anie.201206191
33. Zhu, C.; Xie, W.; Falck, J. R. Chem.-Eur. J. 2011, 17, 12591 - 12595 10.1002/chem.201102475
34. Li, X.; Gong, X.; Zhao, M.; Song, G.; Deng, J.; Li, X. Org. Lett. 2011, 13, 5808 - 5811 10.1021/ol2023856
35. Hesk, D.; Das, P. R.; Evans, B. J. Label. Compd. Radiopharm. 1995, 36, 497 - 502 10.1002/jlcr.2580360514
36. Ellames, G. J.; Gibson, J. S.; Herbert, J. M.; McNeill, A. H. Tetrahedron 2001, 57, 9487 - 9497 10.1016/S0040-4020(01)00945-0
37. Crabtree, R. H.; Felkin, H.; Morris, G. E. J. Organomet. Chem. 1977, 144, 205 - 215 10.1016/S0022-328X(00)92273-3
38. McAuley, B.; Hickey, M. J.; Kingston, L. P.; Jones, J. R.; Lockley, W. J. S.; Mather, A. N.; Spink, E.; Thompson, S. P.; Wilkinson, D. J. J. Label. Compd. Radiopharm. 2003, 46, 1191 - 1204 10.1002/jlcr.780
39. Cross, P. W. C.; Ellames, G. J.; Gibson, J. S.; Herbert, J. M.; Kerr, W. J.; McNeill, A. H.; Mathers, T. W. Tetrahedron 2003, 59, 3349 - 3358 10.1016/S0040-4020(03)00422-8
40. Shu, A. Y. L.; Chen, W.; Heys, J. R. J. Organomet. Chem. 1996, 524, 87 - 93 10.1016/S0022-328X(96)06413-3
41. Catalyst 6 is available commercially from Strem Chemicals, Ltd.
42. Kelly, R. A., III; Clavier, H.; Giudice, S.; Scott, S. M.; Stevens, E. D.; Bordner, J.; Samardjiev, I.; Hoff, C. D.; Cavallo, L.; Nolan, S. P. Organometallics 2008, 27, 202 - 210 10.1021/om701001g
43. Clavier, H.; Nolan, S. P. Chem. Commun. 2010, 46, 841 - 861 10.1039/b922984a
44. Poater, A.; Cosenza, B.; Correa, A.; Giudice, S.; Ragone, F.; Scarano, V.; Cavallo, L. Eur. J. Inorg. Chem. 2009, 1759 - 1766 10.1002/ejic.200801160
45. Nelson, D. J.; Nolan, S. P. Chem. Soc. Rev. 2013, 42, 6723 - 6753 10.1039/c3cs60146c
46. Dröge, T.; Glorius, F. Angew. Chem., Int. Ed. 2010, 49, 6940 - 6952 10.1002/anie.201001865
47. Hirano, K.; Urban, S.; Wang, C.; Glorius, F. Org. Lett. 2009, 11, 1019 - 1022 10.1021/ol8029609
48. Brereton, R. Applied Chemometrics for Scientists; John Wiley & Sons Ltd.: West Sussex, U.K., 2008; Chapter 2.
49. Leardi, R. Anal. Chim. Acta 2009, 652, 161 - 172 10.1016/j.aca.2009.06.015
50. Domagk, G. Dtsch. Med. Wochenschr. 1935, 61, 250 - 253 10.1055/s-0028-1129486
51. Collins, K. D.; Glorius, F. Nat. Chem. 2013, 5, 597 - 601 10.1038/nchem.1669
52. Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med. Chem. 1997, 40, 1347 - 1365 10.1021/jm960803q
53. The intermediacy and catalytic competency of Ir(III) dihydride complexes, derived from COD-bearing Ir(I) complexes and hydrogen gas, has strong literature precedent. See, for example, refs 3e and 5.
54. Perutz, R. N.; Sabo-Etienne, S. Angew. Chem., Int. Ed. 2007, 46, 2578 - 2592 10.1002/anie.200603224
55. Gusev, D. G.; Berke, H. Chem. Ber. 1996, 129, 1143 - 1155 10.1002/cber.19961291002
56. Simmons, E. M.; Hartwig, J. F. Angew. Chem., Int. Ed. 2012, 51, 3066 - 3072 10.1002/anie.201107334
57. All calculations were performed in Gaussian 09 (revision A.02). The M06 density functional was used in conjunction with the 6-31G∗ basis set for main group nonmetal atoms and the Stuttgart RSC effective core potential along with the associated basis set for Ir. Full details and references for all computational methods can be found in the SI.
58. Scheme 4 shows the lowest energy binding modes only. Additional higher energy conformers of benzenesulfonamide binding to both catalysts are discussed in the SI.
59. Similarly to reference 32, Figures 2-4 consider the lowest energy conformers of substrate binding only. Higher energy binding modes are discussed in the SI.
60. Di Giuseppe, A.; Castarlenas, R.; Pérez-Torrente, J. J.; Lahoz, F. J.; Oro, L. A. Chem.-Eur. J. 2014, 20, 8391 - 8403 10.1002/chem.201402499
61. Engle, K. M.; Yu, J.-Q. J. Org. Chem. 2013, 78, 8927 - 8955 10.1021/jo400159y
62. Boutadla, Y.; Davies, D. L.; Macgregor, S. A.; Poblador-Bahamonde, A. I. Dalton Trans. 2009, 5820 - 5831 10.1039/b904967c
63. Crabtree, R. H.; Loch, J. A.; Gruet, K.; Lee, D.-H.; Borgmann, C. J. Organomet. Chem. 2000, 600, 7 - 11 10.1016/S0022-328X(00)00030-9